US Stock MarketDetailed Quotes

Evofem Biosciences (EVFM)

Watchlist
  • 0.0092
  • 0.00000.00%
15min DelayClose Jan 22 15:52 ET
1.17MMarket Cap-0.18P/E (TTM)

Evofem Biosciences (EVFM) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
173.20%336K
-155.83%-2.92M
355.28%560K
56.68%-3.89M
-1,316.47%-2.41M
80.58%-459K
23.63%-1.14M
102.49%123K
87.26%-8.97M
97.40%-170K
Net income from continuing operations
33.66%-1.57M
-232.05%-1.78M
119.88%956K
-116.72%-8.86M
-43.66%-3.04M
-103.58%-2.37M
115.79%1.35M
-104.29%-4.81M
169.07%52.98M
74.64%-2.11M
Operating gains losses
--0
-90.32%3K
-99.21%17K
104.49%3.06M
1,438.30%723K
100.20%143K
-98.36%31K
2,471.43%2.16M
-168.89%-68.15M
-95.26%47K
Depreciation and amortization
-59.86%118K
221.43%135K
350.85%266K
-57.55%756K
438.81%361K
-77.31%294K
112.69%42K
-92.12%59K
-12.95%1.78M
-94.77%67K
Other non cash items
-196.08%-1.35M
7.89%588K
-987.41%-5.01M
70.90%3.08M
0.35%570K
317.00%1.4M
-58.65%545K
-0.18%564K
-44.37%1.8M
5.77%568K
Change In working capital
100.95%1.27M
-43,850.00%-1.76M
95.25%5.3M
-81.66%867K
-157.74%-2.47M
201.94%631K
-100.10%-4K
197.31%2.71M
-21.44%4.73M
-6.09%4.29M
-Change in receivables
164.30%499K
-1,117.04%-3.79M
506.35%8.68M
11.23%-4.09M
-860.10%-4.44M
30.96%-776K
-114.10%-311K
122.81%1.43M
-186.64%-4.61M
-94.98%584K
-Change in inventory
155.09%222K
45.12%357K
-320.97%-864K
-97.29%57K
-123.35%-177K
-12.89%-403K
-86.36%246K
494.95%391K
34.48%2.11M
181.59%758K
-Change in prepaid assets
374.68%423K
86.61%-30K
-81.33%107K
-107.24%-265K
-206.98%-460K
-119.35%-154K
-124.43%-224K
-62.25%573K
41.19%3.66M
-29.74%430K
-Change in payables and accrued expense
-89.45%206K
572.19%2.15M
-811.81%-2.59M
4.43%5.28M
3.13%2.64M
1,674.55%1.95M
214.70%320K
-86.32%364K
339.38%5.05M
145.05%2.56M
-Change in other current liabilities
-783.33%-82K
-1,188.57%-451K
21.74%-36K
92.83%-106K
19.57%-37K
127.27%12K
95.61%-35K
92.22%-46K
-9.16%-1.48M
95.73%-46K
Cash from discontinued investing activities
Operating cash flow
173.20%336K
-155.83%-2.92M
355.28%560K
56.68%-3.89M
-1,316.47%-2.41M
80.58%-459K
23.63%-1.14M
102.49%123K
87.26%-8.97M
97.40%-170K
Investing cash flow
Cash flow from continuing investing activities
0
-2K
-307.14%-57K
-14,125.00%-569K
-46K
-509K
0
-366.67%-14K
98.83%-4K
0
Net PPE purchase and sale
--0
---2K
--0
-250.00%-14K
--0
--0
--0
-366.67%-14K
98.83%-4K
--0
Net other investing changes
--0
--0
---57K
---555K
---46K
----
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
--0
---2K
-307.14%-57K
-14,125.00%-569K
---46K
---509K
--0
-366.67%-14K
98.83%-4K
--0
Financing cash flow
Cash flow from continuing financing activities
-124.45%-244K
123.78%2.56M
-135K
-3.37%4.62M
627.35%2.47M
-53.32%998K
91.62%1.14M
0
-92.29%4.78M
-77.33%340K
Net issuance payments of debt
6.87%-244K
1,677.78%2.56M
---135K
-108.58%-385K
-219.20%-267K
-112.34%-262K
-71.08%144K
--0
-20.01%4.49M
-85.07%224K
Net common stock issuance
----
----
----
--5M
----
----
----
----
--0
----
Proceeds from stock option exercised by employees
----
----
----
--0
--0
--0
--0
--0
-98.85%290K
--116K
Net other financing activities
----
----
----
----
----
--0
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-124.45%-244K
123.78%2.56M
---135K
-3.37%4.62M
627.35%2.47M
-53.32%998K
91.62%1.14M
--0
-92.29%4.78M
-77.33%340K
Net cash flow
Beginning cash position
8.09%748K
60.96%1.11M
27.76%741K
-87.86%580K
76.10%722K
8.81%692K
-55.08%689K
-87.86%580K
-64.85%4.78M
-95.83%410K
Current changes in cash
206.67%92K
-12,133.33%-361K
237.61%368K
103.84%161K
-88.82%19K
113.27%30K
100.33%3K
103.36%109K
52.38%-4.2M
103.36%170K
End cash Position
16.34%840K
8.09%748K
60.96%1.11M
27.76%741K
27.76%741K
76.10%722K
8.81%692K
-55.08%689K
-87.86%580K
-87.86%580K
Free cash flow
173.20%336K
-156.00%-2.92M
413.76%560K
56.54%-3.9M
-1,316.47%-2.41M
80.58%-459K
23.68%-1.14M
102.21%109K
87.32%-8.97M
97.41%-170K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 173.20%336K-155.83%-2.92M355.28%560K56.68%-3.89M-1,316.47%-2.41M80.58%-459K23.63%-1.14M102.49%123K87.26%-8.97M97.40%-170K
Net income from continuing operations 33.66%-1.57M-232.05%-1.78M119.88%956K-116.72%-8.86M-43.66%-3.04M-103.58%-2.37M115.79%1.35M-104.29%-4.81M169.07%52.98M74.64%-2.11M
Operating gains losses --0-90.32%3K-99.21%17K104.49%3.06M1,438.30%723K100.20%143K-98.36%31K2,471.43%2.16M-168.89%-68.15M-95.26%47K
Depreciation and amortization -59.86%118K221.43%135K350.85%266K-57.55%756K438.81%361K-77.31%294K112.69%42K-92.12%59K-12.95%1.78M-94.77%67K
Other non cash items -196.08%-1.35M7.89%588K-987.41%-5.01M70.90%3.08M0.35%570K317.00%1.4M-58.65%545K-0.18%564K-44.37%1.8M5.77%568K
Change In working capital 100.95%1.27M-43,850.00%-1.76M95.25%5.3M-81.66%867K-157.74%-2.47M201.94%631K-100.10%-4K197.31%2.71M-21.44%4.73M-6.09%4.29M
-Change in receivables 164.30%499K-1,117.04%-3.79M506.35%8.68M11.23%-4.09M-860.10%-4.44M30.96%-776K-114.10%-311K122.81%1.43M-186.64%-4.61M-94.98%584K
-Change in inventory 155.09%222K45.12%357K-320.97%-864K-97.29%57K-123.35%-177K-12.89%-403K-86.36%246K494.95%391K34.48%2.11M181.59%758K
-Change in prepaid assets 374.68%423K86.61%-30K-81.33%107K-107.24%-265K-206.98%-460K-119.35%-154K-124.43%-224K-62.25%573K41.19%3.66M-29.74%430K
-Change in payables and accrued expense -89.45%206K572.19%2.15M-811.81%-2.59M4.43%5.28M3.13%2.64M1,674.55%1.95M214.70%320K-86.32%364K339.38%5.05M145.05%2.56M
-Change in other current liabilities -783.33%-82K-1,188.57%-451K21.74%-36K92.83%-106K19.57%-37K127.27%12K95.61%-35K92.22%-46K-9.16%-1.48M95.73%-46K
Cash from discontinued investing activities
Operating cash flow 173.20%336K-155.83%-2.92M355.28%560K56.68%-3.89M-1,316.47%-2.41M80.58%-459K23.63%-1.14M102.49%123K87.26%-8.97M97.40%-170K
Investing cash flow
Cash flow from continuing investing activities 0-2K-307.14%-57K-14,125.00%-569K-46K-509K0-366.67%-14K98.83%-4K0
Net PPE purchase and sale --0---2K--0-250.00%-14K--0--0--0-366.67%-14K98.83%-4K--0
Net other investing changes --0--0---57K---555K---46K--------------------
Cash from discontinued investing activities
Investing cash flow --0---2K-307.14%-57K-14,125.00%-569K---46K---509K--0-366.67%-14K98.83%-4K--0
Financing cash flow
Cash flow from continuing financing activities -124.45%-244K123.78%2.56M-135K-3.37%4.62M627.35%2.47M-53.32%998K91.62%1.14M0-92.29%4.78M-77.33%340K
Net issuance payments of debt 6.87%-244K1,677.78%2.56M---135K-108.58%-385K-219.20%-267K-112.34%-262K-71.08%144K--0-20.01%4.49M-85.07%224K
Net common stock issuance --------------5M------------------0----
Proceeds from stock option exercised by employees --------------0--0--0--0--0-98.85%290K--116K
Net other financing activities ----------------------0----------------
Cash from discontinued financing activities
Financing cash flow -124.45%-244K123.78%2.56M---135K-3.37%4.62M627.35%2.47M-53.32%998K91.62%1.14M--0-92.29%4.78M-77.33%340K
Net cash flow
Beginning cash position 8.09%748K60.96%1.11M27.76%741K-87.86%580K76.10%722K8.81%692K-55.08%689K-87.86%580K-64.85%4.78M-95.83%410K
Current changes in cash 206.67%92K-12,133.33%-361K237.61%368K103.84%161K-88.82%19K113.27%30K100.33%3K103.36%109K52.38%-4.2M103.36%170K
End cash Position 16.34%840K8.09%748K60.96%1.11M27.76%741K27.76%741K76.10%722K8.81%692K-55.08%689K-87.86%580K-87.86%580K
Free cash flow 173.20%336K-156.00%-2.92M413.76%560K56.54%-3.9M-1,316.47%-2.41M80.58%-459K23.68%-1.14M102.21%109K87.32%-8.97M97.41%-170K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More